启动氯氮平治疗患者既往与未来抗精神病药依从性的关联:真实世界观察性研究
该队列研究纳入加拿大魁北克3228例精神分裂症患者,在2009至2016年间启动口服氯氮平,采用药物持有率(MPR)评估启动前后各1年的门诊依从性。结果显示,尽管既往依从性差与启动氯氮平后依从性差相关,但无论既往依从性水平如何,后续依从性差的绝对风险仍较低;启动氯氮平后多数患者依从治疗(对氯氮平>68%,对任何抗精神病药>84%)。作者结论支持在所有符合条件的患者中启动氯氮平。
要点
- 既往抗精神病药依从性差与启动氯氮平后依从性差相关,但后续依从性差的绝对风险仍较低。
- 启动氯氮平后,多数患者依从治疗:对氯氮平>68%,对任何抗精神病药>84%。
- 作者结论支持在所有符合条件的患者中启动氯氮平。
核心结论
- 尽管临床医生普遍认为启动氯氮平前依从性差是处方氯氮平的障碍,本研究支持在所有符合条件的患者中启动氯氮平。
研究设计与样本
- 这项队列研究纳入加拿大魁北克3228例精神分裂症患者,在2009至2016年间启动口服氯氮平(设2年清除期,以启动日期为索引日期)。
- 使用药房数据,通过药物持有率(MPR)测量索引日期前后各1年的门诊治疗依从性。
- 根据既往MPR水平将患者分为五组(自变量);定义两个因变量:启动氯氮平后对任何抗精神病药的良好门诊依从性和仅对氯氮平的良好门诊依从性。
- 采用多重逻辑回归,并使用状态序列分析可视化启动氯氮平前后抗精神病药使用轨迹。
主要发现
- 既往抗精神病药依从性差与启动氯氮平后依从性差相关,但无论既往依从性水平如何,后续依从性差的绝对风险仍较低。
- 启动氯氮平后,多数患者依从治疗:对氯氮平>68%,对任何抗精神病药>84%。
临床怎么用
- 作者结论支持在所有符合条件的患者中启动氯氮平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although recognised as the most effective antipsychotic for treatment-resistant schizophrenia, clozapine remains underused. One reason is the widespread concern about non-adherence to clozapine because of poor adherence before initiating clozapine. AIMS: To determine if prior poor out-patient adherence to treatmentbefore initiating clozapine predisposes to poor out-patient adherence to clozapine or to any antipsychotics (including clozapine) after its initiation. METHOD: This cohort study included 3228 patients with schizophrenia living in Quebec (Canada) initiating (with a 2-year clearance period) oral clozapine (index date) between 2009 and 2016. Using pharmacy data, out-patient adherence to treatment was measured by the medication possession ratio (MPR), over a 1-year period preceding and following the index date. Five groups of patients were formed based on their prior MPR level (independent variable). Two dependent variables were defined after clozapine initiation (good out-patient adherence to any antipsychotics and to clozapine only). Along with multiple logistic regressions, state sequence analysis was used as a visual representation of antipsychotic-use trajectories over time, before and after clozapine initiation. RESULTS: Although prior poor adherence to antipsychotics was associated with poor adherence after clozapine initiation, the absolute risk of subsequent poor adherence remained low, regardless of previous adherence level. Most patients adhered to their treatment after initiating clozapine (>68% to clozapine and >84% to any antipsychotics). CONCLUSIONS: Despite the fact that poor adherence prior to initiating clozapine is widely recognised by clinicians as a barrier for the prescription of clozapine, the current study supports the initiation of clozapine in all eligible patients.
引用
- Brodeur S, Courteau J, Vanasse A, et al. Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study. Br J Psychiatry. 2022. PMID: 35082000. doi:10.1192/bjp.2022.1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。